Suppr超能文献

具有间接反应性的同种异体反应性T细胞的优先启动

Preferential priming of alloreactive T cells with indirect reactivity.

作者信息

Brennan T V, Jaigirdar A, Hoang V, Hayden T, Liu F-C, Zaid H, Chang C K, Bucy R P, Tang Q, Kang S-M

机构信息

Department of Surgery, Division of Transplantation, University of California, San Francisco, CA, USA.

出版信息

Am J Transplant. 2009 Apr;9(4):709-18. doi: 10.1111/j.1600-6143.2009.02578.x.

Abstract

The relative contributions of the direct and indirect pathways in alloimmune responses have not been fully elucidated. We report a novel murine TCR transgenic system that can simultaneously track the CD4-direct (CD4-d), CD4-indirect (CD4-i) and CD8-direct (CD8-d) pathways after transplantation. Using this system, we have observed a profoundly greater proliferation of CD4-i T cells relative to CD4-d and CD8-d T cells after transplantation. Furthermore, a much larger proportion of CD4-i T cells attain an effector phenotype. We also analyzed endogenous, wild-type T cells using enzyme-linked immunospot analysis. In naïve mice, T cells with indirect reactivity were undetectable, but T cells with direct reactivity were abundant. However, 10 days after skin or heterotopic heart transplantation, CD4-i T cells comprised approximately 10% of the CD4+ response. Consistent with increased priming of the CD4-i pathway, we observed that the CD4-i T cells were further enriched in the effector cells migrating to the allograft and in memory-like T cells persisting after rejection. Thus, priming of the CD4-i pathway is favored after transplantation, allowing a rare population to rapidly become a major component of the CD4+ T-cell response in acute allograft rejection. The generalizability of this observation to other models remains to be determined.

摘要

在同种免疫反应中,直接途径和间接途径的相对作用尚未完全阐明。我们报告了一种新型的小鼠TCR转基因系统,该系统能够在移植后同时追踪CD4直接(CD4-d)、CD4间接(CD4-i)和CD8直接(CD8-d)途径。利用该系统,我们观察到移植后CD4-i T细胞相对于CD4-d和CD8-d T细胞有显著更高的增殖。此外,更大比例的CD4-i T细胞获得效应细胞表型。我们还使用酶联免疫斑点分析法分析了内源性野生型T细胞。在未致敏小鼠中,无法检测到具有间接反应性的T细胞,但具有直接反应性的T细胞大量存在。然而,在皮肤或异位心脏移植后10天,CD4-i T细胞约占CD4+反应的10%。与CD4-i途径的启动增加一致,我们观察到CD4-i T细胞在迁移到同种异体移植物的效应细胞和排斥反应后持续存在的记忆样T细胞中进一步富集。因此,移植后CD4-i途径的启动受到青睐,使得一个罕见的群体能够迅速成为急性同种异体移植排斥反应中CD4+ T细胞反应的主要组成部分。这一观察结果在其他模型中的普遍性仍有待确定。

相似文献

1
Preferential priming of alloreactive T cells with indirect reactivity.
Am J Transplant. 2009 Apr;9(4):709-18. doi: 10.1111/j.1600-6143.2009.02578.x.
2
Direct versus indirect allorecognition pathways: on the right track.
Am J Transplant. 2009 Apr;9(4):655-6. doi: 10.1111/j.1600-6143.2009.02572.x.
4
Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
Transplantation. 2007 Apr 15;83(7):931-7. doi: 10.1097/01.tp.0000257960.07783.e3.
6
A direct comparison of rejection by CD8 and CD4 T cells in a transgenic model of allotransplantation.
Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):193-200. doi: 10.1007/s00005-008-0019-0. Epub 2008 May 30.
10
CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
J Immunol. 2005 Feb 1;174(3):1357-64. doi: 10.4049/jimmunol.174.3.1357.

引用本文的文献

3
Protein Phosphatase 2A Activation Promotes Heart Transplant Acceptance in Mice.
Transplantation. 2024 Mar 1;108(3):e36-e48. doi: 10.1097/TP.0000000000004832. Epub 2023 Oct 17.
4
Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival.
Am J Transplant. 2022 Sep;22(9):2237-2245. doi: 10.1111/ajt.17063. Epub 2022 Apr 27.
5
Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft--Host Disease While Preserving Graft-Versus-Leukemia Effect.
Front Immunol. 2022 Feb 28;13:751296. doi: 10.3389/fimmu.2022.751296. eCollection 2022.
6
Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.
Acta Biomater. 2021 Oct 1;133:87-101. doi: 10.1016/j.actbio.2021.05.039. Epub 2021 Jun 5.
7
Engineering immunomodulatory biomaterials for type 1 diabetes.
Nat Rev Mater. 2019 Jun;4(6):429-450. doi: 10.1038/s41578-019-0112-5. Epub 2019 May 17.
9
Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges.
Cell Stem Cell. 2018 Jun 1;22(6):810-823. doi: 10.1016/j.stem.2018.05.016.
10
Dendritic Cell Therapy in Transplantation, Phenotype Governs Destination and Function.
Transplantation. 2018 Oct;102(10):1593-1594. doi: 10.1097/TP.0000000000002238.

本文引用的文献

4
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects.
Am J Transplant. 2007 Jun;7(6):1457-63. doi: 10.1111/j.1600-6143.2007.01829.x.
5
Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance.
Am J Transplant. 2007 Jun;7(6):1442-9. doi: 10.1111/j.1600-6143.2007.01816.x.
6
Competition for antigen determines the stability of T cell-dendritic cell interactions during clonal expansion.
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4553-8. doi: 10.1073/pnas.0610019104. Epub 2007 Mar 2.
7
Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response.
J Exp Med. 2005 May 16;201(10):1555-65. doi: 10.1084/jem.20042521.
8
Activation and migration of allo-peptide specific TCR transgenic T cells in cardiac allograft rejection.
Cell Immunol. 2004 Jul;230(1):44-55. doi: 10.1016/j.cellimm.2004.09.001.
9
Frontline: Peripheral priming of alloreactive T cells by the direct pathway of allorecognition.
Eur J Immunol. 2004 Dec;34(12):3305-14. doi: 10.1002/eji.200425309.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验